by David Eyre | Dec 6, 2024 | Uncategorised
Haemophilia B A blot clot is produced following a cascade of reactions after injury. Haemophilia is a disorder of blood clotting whereby one of the factors that contributes to this cascade of reactions is defective. Consequently, for sufferers from this condition...
by David Eyre | Sep 16, 2024 | US & International
Background For valuable inventions it is relatively typical for a US patent to be expanded into a family of patent rights. Naturally, the value of patents is further enhanced by extra patent term. Patents with expiry dates beyond the normal 20 year period can be...
by Sean Hutchinson | Aug 30, 2024 | EPO
Background European patent no. EP 2 991 507 B1 was granted with claims directed to a mixture containing fish oil and fruit juice for use in the treatment of cancer. At opposition, the patent was found to lack novelty and the amendments proposed by the patent...
by Chloe Sullivan | Aug 29, 2024 | EPO
Background Due to methods of treatment of the human or animal body being excluded from patentability in Europe, applicants are required to claim substances or compositions for use in a method of treatment instead. Thus, there is a need for the term “substances or...
by Sean Hughes | Jul 11, 2024 | EPO
Vegan Cheese Product Claim T 0629/22 concerned European patent no. 3422865 (subject-matter: vegan cheese and preparation thereof). The product claim was distinguished from the prior art according to the type and amount of starch used in the vegan cheese. However, the...
Recent Comments